SiBreaX develops drugs based on targeted drug delivery via a unique delivery system. For the first time, SiBreaX technology of triggered-breakable silicate nanoparticles opens access to the efficient delivery of peptides and proteins into target cells. With our technology, we access the targeted delivery of drugs to treat lung, liver, and immune cell borne diseases.